Skip to content

To assess the efficacy of Vyadhi Shardula Guggulu and Simhanada Guggulu along with Rasna Dashamula Kwatha in the management of Amavata (rheumatoid arthritis).

A randomized comparative clinical trial to evaluate the efficacy of Vyadhi Shardula Guggulu and Simhanada Guggulu along with Rasna Dashamula Kwatha in the management of Amavata (rheumatoid arthritis). - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085390
Enrollment
50
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

National Institute of Ayurveda Deemed to be University Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender, aged 25 to 60 years. Patients exhibiting signs and symptoms of Amavata (Rheumatoid Arthritis). Patients who fulfill the criteria of ACR/EULAR 2010 criteria (American College of Rheumatology/European League Against Rheumatism). Patients with a chronicity of less than 5 years.

Exclusion criteria

Exclusion criteria: Patients with severe crippling joint deformities. Patients with associated cardiac disease, uncontrolled diabetes mellitus, malignant hypertension, or any conditions that may interfere with the outcome of interest. Pregnant women and lactating mothers. Patients taking disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis.

Design outcomes

Primary

MeasureTime frame
Change in disease activity as measured by the DAS-28 score.Timepoint: Baseline and 8 weeks.

Secondary

MeasureTime frame
Changes in symptom score. Changes in the HAQ-DI score. Changes in functional capacity by assessing walking time, hand & foot grip. Changes in inflammatory markers: ESR, CRP.Timepoint: Baseline, 4 weeks, & 8 weeks

Countries

India

Contacts

Public ContactDr Ajay Kumar Sahu

National Institute of Ayurveda

drajaysahu@gmail.com9950708106

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026